 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: TYRUKO (natalizumsb-sztn) |
|
***************************************************** |
|
#Post#: 4530-------------------------------------------------- |
|
FDA-approved Tyruko (natalizumab-sztn) |
|
By: agate Date: August 27, 2024, 12:47 am |
|
--------------------------------------------------------- |
|
Tyruko is a Tysabri biosimilar. It is administered as a 1-hour |
|
IV infusion, every 4 weeks. |
|
https://www.tyruko.com/ |
|
#Post#: 4531-------------------------------------------------- |
|
Re: FDA-approved Tyruko (natalizumab-sztn) |
|
By: agate Date: August 27, 2024, 12:59 am |
|
--------------------------------------------------------- |
|
I'm not sure just how available this drug currently is. It looks |
|
as if it's available only through a restricted program but this |
|
information is from April 2024: |
|
https://hhs.iowa.gov/media/13171/download?inline= |
|
***************************************************** |
